Cephalosporin C

Cephalosporin C is an antibiotic of the cephalosporin class. It was isolated from fungi of the genus Acremonium and first characterized in 1961. Although not a very active antibiotic itself, synthetic analogs of cephalosporin C, such as cefalotin, became some of the first marketed cephalosporin antibiotic drugs. Cephalosporin C is an antibiotic of the cephalosporin class. It was isolated from fungi of the genus Acremonium and first characterized in 1961. Although not a very active antibiotic itself, synthetic analogs of cephalosporin C, such as cefalotin, became some of the first marketed cephalosporin antibiotic drugs. Cephalosporin C strongly absorbs ultraviolet light, is stable to acid and penicillin, is non-toxic and has in vivo activity in mice. Cephalosporin C, which has a similar structure to penicillin N, was never commercialized. Cephalosporin C is a Lead compound for the discovery and production of many other cephalosporins. Cephalosporins are drugs used for some people who are allergic to penicillin. Cephalosporins are used to treat bacterial infecions such as respiratory tract infections, skin infections and urinary tract infections. When cephalosporins, along with any Antibiotic, is given as a treatment, take the medication for the fully prescribed time even if symptoms disappear. These are allergic reactions to the drug and should seek medical attention: Cephalosporin C has weak activity to the staphylococci infection, which was 0.1% activity. This decrease in activity was due to the replacement of the D-α-aminoadipic acid side chain with phenylacetic acid. The protein that cephalosporin C interacts with is Penicillin binding proteins. Biochemistry Cephalosporin C is the product of the biosynthesis pathway of third generation cephalosporins. This is done by exchanging the acetyl CoA into DAC.